Hyperkalaemia and hypokalaemia outpatient management: a survey of 500 French genera practitioners
Open Access
- 1 October 2020
- journal article
- research article
- Published by Wiley in ESC Heart Failure
- Vol. 7 (5), 2042-2050
- https://doi.org/10.1002/ehf2.12834
Abstract
Aims How general practitioners (GPs) manage dyskalaemia is currently unknown. This study aimed at describing GP practices regarding hypokalaemia or hyperkalaemia diagnosis and management in their outpatients. Methods and results A telephone survey was conducted among French GPs with a 20-item questionnaire (16 closed-ended questions and 12 open-ended questions) regarding their usual management of hypokalaemia or hyperkalaemia patients, both broadly and more specifically in patients with heart failure and/or chronic kidney disease and/or in patients treated with angiotensin-converting enzyme/angiotensin receptor blockers or mineralocorticoid receptor antagonists. We aimed to interview 500 GPs spread geographically throughout France. This descriptive survey results are presented as mean +/- standard deviation (if normally distributed or as median and inter-quartile range if the distribution was skewed). Categorical variables are expressed as frequencies and proportions (%). A total of 500 GPs participated in the study. Dyskalaemia thresholds (for diagnosis and intervention) and management patterns were highly heterogeneous. The mean +/- SD (range) potassium level leading to 'intervene' was 5.32 +/- 0.34 mmol/L (4.5-6.5) for hyperkalaemia and 3.23 +/- 0.34 mmol/L (2.0-6.5) for hypokalaemia. Potassium levels leading to refer the patient to the emergency department (ED) were 6.14 +/- 0.55 (4.5-10) and 2.69 +/- 0.42 mmol/L (1-4), respectively. Potassium binders (51-65%) or potassium supplements (67-74%) were frequently used to manage hyperkalaemia or hypokalaemia. GPs uncommonly referred their dyskalaemic patients to cardiologists or nephrologists (or to the emergency department, if the latter was deemed necessary owing to the severity of the dyskalaemia). We identified an association between the close vicinity of GP office from an ED and 'referring a heart failure patient' (19.2% with ED vs. 8.6% without ED) and referring a heart failure and chronic kidney disease patient on mineralocorticoid receptor antagonist (16.7% with ED vs. 9.3% without ED). Although the majority (67%) of GPs had an electrocardiogram on hand, it was rarely used (14%) in dyskalaemic patients. Subgroup analyses considering gender, age of the participating GPs, and high-income/low-income regions did not identify specific patterns regarding the multidimensional aspect of dyskalaemia management. Conclusions Owing to the considerable heterogeneity of French GP practices toward dyskalaemia diagnosis and management approaches, there is a likely need to standardize (potentially enabled by therapeutic algorithms) practices.Funding Information
- Lorraine Université d'Excellence (ANR-15-IDEX-04-LUE)
- RHU Fight-HF (ANR-15-RHUS-0004)
This publication has 26 references indexed in Scilit:
- Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunctionEuropean Journal of Heart Failure, 2020
- Management of hyperkalemia in the acutely ill patientAnnals of Intensive Care, 2019
- A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrologyEuropean Heart Journal Supplements, 2019
- Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of MortalityCirculation, 2018
- Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the futurePharmacological Research, 2016
- European Resuscitation Council Guidelines for Resuscitation 2015Resuscitation, 2015
- Serum Potassium Levels and Mortality in Acute Myocardial InfarctionJAMA, 2012
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung TransplantationJournal of the American College of Cardiology, 2009
- Retrospective Review of the Frequency of ECG Changes in HyperkalemiaClinical Journal of the American Society of Nephrology, 2008
- Electrocardiographic manifestations of hyperkalemiaThe American Journal of Emergency Medicine, 2000